Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sundia Meditech has reported that NovaSecta has joined in a strategic alliance with Sundia Meditech and HD BioSciences to provide drug discovery solutions for European pharmaceutical and biotech companies.
Subscribe to our email newsletter
The alliance is expected to bring together the high quality scientific capabilities of Sundia and HD BioSciences with NovaSecta’s extensive client base and unique understanding of European mid-sized pharmaceutical and biotech companies.
Xiaochuan Wang, Sundia Meditech’s founder and CEO and Xuehai Tan, founder and CEO of HD BioSciences, said: “We believe that by extending our alliance to include NovaSecta, we will bring significant benefits to European customers, so we look forward to working with NovaSecta and more European clients.”